Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van der Meulen

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Frontiers in Nuclear Medicine|December 8, 2025
First positronium lifetime imaging with scandium-44 on a long axial field-of-view PET/CTLorenzo Mercolli, William M Steinberger, Pascal V Grundler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
JAMA|June 17, 2015
Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation ModelReinier G S Meester, Chyke A Doubeni, Iris Lansdorp-Vogelaar, et al.
Dalton Transactions (Cambridge, England : 2003)|August 22, 2017
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with <sup>152</sup>Tb-DOTATOCRichard P Baum, Aviral Singh, Martina Benešová, et al.
Journal of Clinical Epidemiology|October 16, 2004
Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosisB J Bouma, J H P van der Meulen, R B A van den Brink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
First-in-Humans Application of <sup>161</sup>Tb: A Feasibility Study Using <sup>161</sup>Tb-DOTATOCRichard P Baum, Aviral Singh, Harshad R Kulkarni, et al.
BMJ Open|January 17, 2024
Potential impact of a new sepsis prediction model for the primary care setting: early health economic evaluation using an observational cohortFeike J Loots, Miriam P van der Meulen, Marleen Smits, et al.
EJNMMI Research|June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing miceFrancesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2015
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal NeoplasiaAtija Kapidzic, Miriam P van der Meulen, Lieke Hol, et al.
Frontiers in Medicine|October 29, 2021
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICISReinhard Heinke, Eric Chevallay, Katerina Chrysalidis, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Frontiers in Nuclear Medicine|December 8, 2025
First positronium lifetime imaging with scandium-44 on a long axial field-of-view PET/CTLorenzo Mercolli, William M Steinberger, Pascal V Grundler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 11, 2025
Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 StudyJulia G Fricke, Frida Westerbergh, Lisa McDougall, et al.
JAMA|June 17, 2015
Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation ModelReinier G S Meester, Chyke A Doubeni, Iris Lansdorp-Vogelaar, et al.
Dalton Transactions (Cambridge, England : 2003)|August 22, 2017
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with <sup>152</sup>Tb-DOTATOCRichard P Baum, Aviral Singh, Martina Benešová, et al.
Journal of Clinical Epidemiology|October 16, 2004
Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosisB J Bouma, J H P van der Meulen, R B A van den Brink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
First-in-Humans Application of <sup>161</sup>Tb: A Feasibility Study Using <sup>161</sup>Tb-DOTATOCRichard P Baum, Aviral Singh, Harshad R Kulkarni, et al.
BMJ Open|January 17, 2024
Potential impact of a new sepsis prediction model for the primary care setting: early health economic evaluation using an observational cohortFeike J Loots, Miriam P van der Meulen, Marleen Smits, et al.
EJNMMI Research|June 13, 2019
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing miceFrancesco Cicone, Silvano Gnesin, Thibaut Denoël, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2015
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal NeoplasiaAtija Kapidzic, Miriam P van der Meulen, Lieke Hol, et al.
Frontiers in Medicine|October 29, 2021
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICISReinhard Heinke, Eric Chevallay, Katerina Chrysalidis, et al.
Pageof 17